Spanish Registry on Heart Transplantation. Twenty-two Official Report of the Working Group on Heart Failure and Heart Transplantation of the Spanish Society of Cardiology (1984-2010)

被引:0
作者
Almenar, Luis [1 ]
Segovia, Javier [2 ,3 ]
Crespo-Leiro, Maria G. [4 ]
Palomo, Jesus [5 ]
Arizon, Jose M. [6 ]
Cobo, Manuel [7 ]
Delgado, Juan [8 ]
机构
[1] Registro Espanol Trasplante Cardiaco, Secc Insuficiencia Cardiaca Trasplante Cardiaco S, Valencia, Spain
[2] Hosp Univ & Politecn La Fe Valencia, Avda Bulevar Sur S-N, Valencia 46026, Spain
[3] Clin Puerta Hierro Majadahonda, Madrid, Spain
[4] Hosp Univ A Coruna, La Coruna, Spain
[5] Hosp Gregorio Maranon, Madrid, Spain
[6] Hosp Reina Sofia, Cordoba, Spain
[7] Hosp Marques Valdecilla, Santander, Spain
[8] Hosp 12 Octubre, Madrid, Spain
来源
CIRUGIA CARDIOVASCULAR | 2011年 / 18卷 / 01期
关键词
Heart transplantation; Registry; Survival;
D O I
10.1016/S1134-0096(11)70075-4
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective. The purpose of this report is to present the results obtained with heart transplantation (HT) since this therapeutic modality first began to be used in Spain in May 1984. Materials and methods. A descriptive analysis was performed of all HT performed until December 31, 2010. Results. The total number of transplants is 6,291. The average clinical profile of the Spanish heart transplant patient in 2010 was that of a 53-year-old male who had been diagnosed with nonrevas-cularizable ischemic heart disease accompanied by severely depressed ventricular function and poor functional status. The implanted heart was typically from a 39-year-old donor who had died from brain hemorrhage. The average waiting list time was 99 days. Mean survival time has progressively increased over the years. Whereas for the overall series, the probability of survival at 1, 5, 10 and 15 years was 78, 67, 54 and 40%, respectively, over the past 5 years, the probability of survival at 1 and 5 years was 85 and 73%, respectively. The most frequent cause of death was acute graft failure (16.5%), followed by infection (15.9%), the combination of graft vascular disease and sudden death (13.7%), tumors (11.9%) and acute rejection (7.8%). Conclusions. The survival rates obtained in Spain with HT, especially in recent years, position heart transplant as the treatment of choice in irreversible heart failure patients without other established medical or surgical options.
引用
收藏
页码:41 / 52
页数:12
相关论文
共 25 条
[1]  
Almenar Bonet L, 2010, REV ESP CARDIOL, V63, P1317
[2]  
Bonet LA, 2006, REV ESP CARDIOL, V59, P1283
[3]   Spanish Heart Transplantation Registry. 20th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2008) [J].
Almenar Bonet, Luis .
REVISTA ESPANOLA DE CARDIOLOGIA, 2009, 62 (11) :1286-1296
[4]  
Arizon del Prado J M, 1993, REV ESP CARDIOL, V46, P791
[5]  
Arizon del Prado JM, 1995, REV ESP CARDIOL, V48, P792
[6]  
Arizon J M, 1992, Rev Esp Cardiol, V45, P618
[7]   The Registry of the International Society for Heart and Lung Transplantation: Thirteenth official pediatric lung and heart-lung transplantation report-2010 [J].
Aurora, Paul ;
Edwards, Leah B. ;
Kucheryavaya, Anna Y. ;
Christie, Jason D. ;
Dobbels, Fabienne ;
Kirk, Richard ;
Rahmel, Axel O. ;
Stehlik, Josef ;
Hertz, Marshall I. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (10) :1129-1141
[8]  
Bonet LA, 1999, REV ESP CARDIOL, V52, P153
[9]  
Bonet LA, 2005, REV ESP CARDIOL, V58, P232
[10]  
Bonet LA, 2004, REV ESP CARDIOL, V57, P1197